HUE061625T2 - Nagytisztaságú cukrok és cukorkészítmények - Google Patents
Nagytisztaságú cukrok és cukorkészítményekInfo
- Publication number
- HUE061625T2 HUE061625T2 HUE16197420A HUE16197420A HUE061625T2 HU E061625 T2 HUE061625 T2 HU E061625T2 HU E16197420 A HUE16197420 A HU E16197420A HU E16197420 A HUE16197420 A HU E16197420A HU E061625 T2 HUE061625 T2 HU E061625T2
- Authority
- HU
- Hungary
- Prior art keywords
- highly purified
- sugar compositions
- purified sugars
- sugars
- sugar
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16197420.9A EP3318281B1 (en) | 2016-11-04 | 2016-11-04 | Highly purified sugars and sugar compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE061625T2 true HUE061625T2 (hu) | 2023-07-28 |
Family
ID=57240981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE16197420A HUE061625T2 (hu) | 2016-11-04 | 2016-11-04 | Nagytisztaságú cukrok és cukorkészítmények |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3318281B1 (hu) |
DK (1) | DK3318281T3 (hu) |
ES (1) | ES2939944T3 (hu) |
FI (1) | FI3318281T3 (hu) |
HU (1) | HUE061625T2 (hu) |
PL (1) | PL3318281T3 (hu) |
PT (1) | PT3318281T (hu) |
SI (1) | SI3318281T1 (hu) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116143850B (zh) * | 2022-12-22 | 2023-12-15 | 中粮崇左糖业有限公司 | 一种注射级蔗糖、制备方法及其用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096136A (en) | 1996-10-18 | 2000-08-01 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Method for producing white sugar |
US6464881B2 (en) | 1996-10-21 | 2002-10-15 | Orelis | Inorganic nanofiltration membrane and its application in the sugar industry |
US6406548B1 (en) | 2000-07-18 | 2002-06-18 | Tate & Lyle Industries, Limited | Sugar cane membrane filtration process |
BR0015571A (pt) * | 1999-11-17 | 2002-07-30 | Tate & Lyle Ind Ltd | Processo para produzir sacarose a partir de um xarope contendo sacarose |
CA2930485C (en) * | 2003-05-14 | 2018-04-10 | Immunogen, Inc. | Maytansinoid-antibody conjugate compositions |
FR2995214B1 (fr) * | 2012-09-10 | 2014-11-21 | Adocia | Solution a viscosite reduite de proteine a concentration elevee |
SG11201610316XA (en) * | 2014-06-13 | 2017-01-27 | Avantor Performance Mat Inc | High purity low endotoxin carbohydrate (hple) compositions, and methods of isolation thereof |
-
2016
- 2016-11-04 SI SI201631670T patent/SI3318281T1/sl unknown
- 2016-11-04 DK DK16197420.9T patent/DK3318281T3/da active
- 2016-11-04 HU HUE16197420A patent/HUE061625T2/hu unknown
- 2016-11-04 PL PL16197420.9T patent/PL3318281T3/pl unknown
- 2016-11-04 PT PT161974209T patent/PT3318281T/pt unknown
- 2016-11-04 FI FIEP16197420.9T patent/FI3318281T3/fi active
- 2016-11-04 EP EP16197420.9A patent/EP3318281B1/en active Active
- 2016-11-04 ES ES16197420T patent/ES2939944T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
PT3318281T (pt) | 2023-02-07 |
SI3318281T1 (sl) | 2023-04-28 |
ES2939944T3 (es) | 2023-04-28 |
FI3318281T3 (fi) | 2023-03-21 |
PL3318281T3 (pl) | 2023-05-15 |
EP3318281A1 (en) | 2018-05-09 |
DK3318281T3 (da) | 2023-02-27 |
EP3318281B1 (en) | 2022-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL251527A0 (en) | Preparations of adenosine deaminase-2 (ada2), their variants and methods of using them | |
EP3397261A4 (en) | METHODS AND COMPOSITIONS RELATING TO THE CHONDRISOMES | |
IL251211A0 (en) | Saccharides and saccharide preparations and mixtures | |
EP3325620A4 (en) | ANTIVIRAL PROCEDURES AND COMPOSITIONS | |
EP3297455A4 (en) | GLYCOSIDZUSAMMENSETZUNGEN | |
EP3283507B8 (en) | Acylated glucagon analogue | |
SG11201707876YA (en) | Microalgal compositions and uses thereof | |
EP3281534A4 (en) | Erythritol-containing sweetener composition | |
HK1258260A1 (zh) | 沒有或幾乎沒有糖的穩定的干組合物 | |
EP3223628A4 (en) | Glycoside compositions | |
IL290057A (en) | Pure preparations of oligosaccharides of breast milk | |
HK1254978A1 (zh) | 含萊鮑迪甙d的甜味劑組合物 | |
EP3399957A4 (en) | SKIN REFRESHING COMPOSITIONS | |
EP3491153A4 (en) | COMPOSITION CONTAINING SUGAR | |
EP3273952A4 (en) | Methods and compositions to inhibit symptoms associated with veisalgia | |
EP3305085A4 (en) | CHOCOLATE | |
EP3367816A4 (en) | STEVIOL GLYCOSIDE COMPOSITIONS | |
EP3389403A4 (en) | STEVIOL GLYCOSIDE COMPOSITIONS | |
IL247550B (en) | Glycoprotein composition with sialyl and its uses | |
PT3318281T (pt) | Açúcares altamente purificados e composições de açúcar | |
SG10201807121QA (en) | Sugar Composition | |
AU2016902954A0 (en) | Sugar composition | |
GB201614449D0 (en) | Sweetener composition | |
GB201521961D0 (en) | Polo sweets | |
EP3383985A4 (en) | CLEANING COMPOSITION |